Contact
Please use this form to send email to PR contact of this press release:
FDA grants traditional approval to daratumumab and hyaluronidase-fihj for newly diagnosed light chain amyloidosis
TO:
Please use this form to send email to PR contact of this press release:
FDA grants traditional approval to daratumumab and hyaluronidase-fihj for newly diagnosed light chain amyloidosis
TO: